Sarah Jessica Parker Ends Mylan Partnership Over EpiPen Price Hike
Sarah Jessica Parker has ended her relationship with the controversial pharmaceutical company Mylan.
In May, the actress joined forces with the makers of the EpiPen through a campaign called Anaphylaxis for Reel. At the time, Parker urged awareness for life-threatening allergies and revealed that the issue is personal for her because her 13-year-old son, James Wilke Broderick has a severe peanut and hazelnut allergy.
More...